Invention in the REGENERATIVE MEDICINE is what we do every day, benefits of patients is our final goal


Get in touch!

LD Biopharma Inc.


6042 Cornerstone CT. W. Suite E
San Diego, CA 92121

Tel: 858-876-8266
Fax: 858-638-0488

Recombinant Protein

TF Trap



Home > News

In vitro generation of HSC-like cells from murine ESCs/iPSCs by enforced expression of Lhx2

Identification of genes involved in in vitro differentiation induction of embryonic stem cells (ESCs) into hematopoietic stem cells (HSCs) has been challenged during last decade. To date, a homeobox transcription factor Hoxb4 has been only demonstrated to possess such an effect in mice. Here, we show that HSC-like cells were efficiently induced from mouse ESCs by enforced expression of Lhx2, a LIM-homeobox transcription factor. Transduction of Lhx2 into ESC-derived mesodermal cells resulted in robust differentiation of c-Kit+/Sca-1+/Lineage- (KSL) cells in vitro. The KSL cell induction frequency was superior to the case of Hoxb4. Furthermore, transplantation of Lhx2-transduced hematopoietic cells into lethally irradiated mice resulted in multi-lineage repopulation of hematopoietic cells over 4 months. Transduction of Lhx2 into induced pluripotent stem cells (iPSCs) was also effective in generating KSL cells in vitro, as well as HSC-like activities in vivo. These results demonstrate that ectopic expression of Lhx2 confers an in vivo engrafting capacity to ESC/iPSC-derived hematopoietic cells and in vivo behavior of iPSCderived hematopoietic cells is almost identical to that of ESC-derived cells.

Information about reproducing this article in parts or in its entirety may be found online at:

Information about ordering reprints may be found online at:

Information about subscriptions and ASH membership may be found online at: